KEYTRUDA

Merck Canada Inc🇨🇦 Health Canada

Approval Id: f1d88b66c85ee090
Drug Approval Canada Name: KEYTRUDA
Product Name: KEYTRUDA
Status: Marketed
Status Date: 2017-07-13
Original Market Date: 2017-07-13
Din: 02456869
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 10:00.00
Atc Original: L01FF02 PEMBROLIZUMAB
Atc Name: l 01 ff 02
Aig Number: 0156910003
Company Name: Merck Canada Inc
Company Address: 16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7

PEMBROLIZUMAB

25 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f1d88b66c85ee090

Type

Standard